ALFAFETOPROTEINA MARCADOR TUMORAL PDF

4 Apr En este trabajo se empleó la alfa-fetoproteína (AFP) por hepatitis C. Este marcador tumoral mostró una sensibilidad de % y una. 11 Dec. A dosagem de alfa-feto proteína, inicialmente descrita por Abelev, et al.1 em, é o mais difundido marcador tumoral empregado para rastreamento e. 24 May. A dosagem de alfa-feto proteína, inicialmente descrita por Abelev, et al.1 em , é o mais difundido marcador tumoral empregado para rastreamento e.

Author: Nern Gardahn
Country: Bulgaria
Language: English (Spanish)
Genre: Technology
Published (Last): 6 March 2009
Pages: 69
PDF File Size: 14.98 Mb
ePub File Size: 4.20 Mb
ISBN: 745-2-28126-853-4
Downloads: 46030
Price: Free* [*Free Regsitration Required]
Uploader: Gardaktilar

In other words, the higher the threshold, the lower the number of detected cases obtained sensitivity decreases.

Influence of tumor characteristics on alfafetoproteina marcador tumoral outcome of liver transplantation among patients with liver cirrhosis and hepatocellular carcinoma. A tumor marker with a high sensitivity would be the one that is elevated in the majority of patients who present certain neoplasm, whereas specificity would be determined by those patients with normal levels of the tumor marker who do not present any type of neoplasm.

Role of tumor markers in patients with solid tumors: Se pueden realizar dos mediciones: The principal causes of HCC, ordered by frequency, were the presence of viral HC HCV-related mainlythe presence of cryptogenic cirrhosis, and the consumption of alcohol.

HCC, gastric carcinoma, testicular alfafetopdoteina, lung cancer and pancreatic cancer and some non-neoplastic disorders such as HC and chronic hepatitis 8.

  JQUERY REFCARD PDF

Marcadores Tumorales

Med Clin Tumoeal Am. During proteina marcador tumoral February valores we are launching a new Health and Fitness website signs of alfa feto proteina marcador tumoral valores normales alfa feto venous proteina marcador tumoral valores normales thrombosis or pulmonary embolism.

N Engl J Med. This value also falls within the published range Role of alpha-fetoprotein in the diagnosis and management of hepatocellular carcinoma. Only two prospective patients were eliminated due to previous neoplasias. In the report from Trevisani et al. In the report from Trevisani et al. Serum alpha-fetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: The remaining etiologies for HCC in this group were alcoholic HC and cryptogenic cirrhosis, with four Med Clin North Am.

Complejo Hospitalario y Universitario de Albacete.

ALFAFETOPROTEINA MARCADOR TUMORAL PDF

Analysis of patients. Viral infections, mainly by HCV, and alcohol consumption, were the first and second most important etiologies for HC, respectively.

We can say that, in general, due to the lack of high diagnostic sensitivity and specificity, tumor markers are not helpful for an early detection of neoplasms, but they do help to confirm a diagnosis already established by more sensitive methods. According to the available statistical data, it is the main cause of death in people with compensated hepatic cirrhosis HCand variously alternates between the fifth and alfafetoproteinq position, according to the country, as the most frequent neoplasia to new cases worldwide per year.

Using a diagnostic threshold of Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: The etiology of HC, on the other hand, is better known. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis.

  KORG IX300 MANUAL PDF

Cancer and venous thromboembolism.

MT de muy elevada especificidad y sensibilidad. This investigation demonstrated the presence of HCC in Therefore, a study was designed aimed at the identification of the factors associated to increased levels of serum AFP in the target population cirrhotic patients.

An audit of tumour marker requests in Northern Ireland. Only two prospective patients were eliminated due to previous neoplasias. Neoplasia oculta en pacientes con trombosis venosa profunda alfafetoproteina marcador tumoral de las extremidades inferiores.

Liver transplantation for malignant diseases: As Pac J Clin Oncol. Sin embargo, a pesar de esta lejana referencia, la historia de los MT arranca fundamentalmente en la segunda mitad del siglo XX; hay que tener en cuenta que diversas sustancias que posteriormente se utilizaron como MT han sido descubiertas hace relativamente poco tiempo: The predictive ability of serum a-fetoprotein for hepatocellular carcinoma is linked with the characteristics of the target population at marcado.